Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 5116 [2015-01769]

Download as PDF 5116 Federal Register / Vol. 80, No. 20 / Friday, January 30, 2015 / Notices health equity issues and provide guidance on opportunities for CDC. Matters for Discussion: The Health Disparities Subcommittee members will discuss progress toward implementation of the Health Disparities Subcommittee recommendations and discussion of the Healthy People 2020 progress review on social determinants of health and LGBT health. The agenda is subject to change as priorities dictate. Contact Person for More Information: Leandris Liburd, Ph.D., M.P.H., M.A., Designated Federal Officer, Health Disparities Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton Road NE., M/S K–77, Atlanta, Georgia 30333 Telephone (770) 488–8343, Email: LEL1@ cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 2015–01766 Filed 1–29–15; 8:45 am] BILLING CODE 4163–18–P The meeting announced below concerns Occupational Safety and Health Education and Research Centers (ERC) PAR 10–217, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: asabaliauskas on DSK5VPTVN1PROD with NOTICES Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Times and Dates: 6:00 p.m.–8:00 p.m., February 23, 2015 (Closed). 8:00 a.m.–6:00 p.m., February 24, 2015 (Closed). 8:00 a.m.–6:00 p.m., February 25, 2015 (Closed). 8:00 a.m.–6:00 p.m., February 26, 2015 (Closed). Place: Renaissance Atlanta Midtown Hotel, 866 West Peachtree Street NW., Atlanta, Georgia 30308, Telephone: (678) 412–2400. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Jkt 235001 George Bockosh, M.S., Scientific Review Officer, National Institute for Occupational Safety and Health (NIOSH), CDC, 2400 Century Center Parkway NE., 4th Floor, Mailstop E–74, Atlanta, Georgia 30345, Telephone: (412) 386–6465, GGB0@CDC.GOV and Donald Blackman, Ph.D., Scientific Review Officer, NIOSH, CDC, 2400 Century Center Parkway NE., 4th Floor, Room 4204, Mailstop E–74, Atlanta, Georgia 30345, Telephone: (404) 498– 6185, DYB7@CDC.GOV. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. BILLING CODE 4163–18–P Centers for Disease Control and Prevention 18:50 Jan 29, 2015 FOR FURTHER INFORMATION CONTACT: [FR Doc. 2015–01817 Filed 1–29–15; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Sep<11>2014 Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Occupational Safety and Health Education and Research Centers (ERC) PAR 10–217.’’ Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns ‘‘Comprehensive High-Impact HIV Prevention Projects for CommunityBased Organizations’’, Funding Opportunity Announcement (FOA) PS15–1502, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Times and Dates: 9:00 a.m.–4:00 p.m. EST, Panels 1–7; February 24, 2015 (Closed), 9:00 a.m.–4:00 p.m. EST, Panels 8–14; February 25, 2015 (Closed), 9:00 a.m.–4:00 p.m. EST, Panels 15–19; February 26, 2015 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Comprehensive High-Impact HIV Prevention Projects for CommunityBased Organizations’’ FOA PS15–1502. Contact Person for More Information: Lisa R. Williams, Public Health Analyst, CDC, 1600 Clifton Road NE., Mailstop E07, Atlanta, Georgia 30333, Telephone: (404) 639–1877. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–01769 Filed 1–29–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting of the aforementioned committee. Times and Dates: 8:00 a.m.–5:45 p.m., February 25, 2015. 8:00 a.m.–1:00 p.m., February 26, 2015. Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton Road NE., Building 19, Kent ‘‘Oz’’ Nelson Auditorium, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Purpose: The committee is charged with advising the Director, CDC, on the appropriate use of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines. Further, under provisions of the Affordable Care Act, at section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have been adopted by the Director of the Centers for Disease Control and Prevention must be covered by applicable health plans. Matters for discussion: The agenda will include discussions on: General recommendations; meningococcal vaccines; human papillomavirus vaccines; influenza; E:\FR\FM\30JAN1.SGM 30JAN1

Agencies

[Federal Register Volume 80, Number 20 (Friday, January 30, 2015)]
[Notices]
[Page 5116]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01769]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns ``Comprehensive High-Impact 
HIV Prevention Projects for Community-Based Organizations'', Funding 
Opportunity Announcement (FOA) PS15-1502, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Times and Dates: 9:00 a.m.-4:00 p.m. EST, Panels 1-7; February 
24, 2015 (Closed), 9:00 a.m.-4:00 p.m. EST, Panels 8-14; February 
25, 2015 (Closed), 9:00 a.m.-4:00 p.m. EST, Panels 15-19; February 
26, 2015 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Comprehensive High-Impact HIV Prevention Projects for 
Community-Based Organizations'' FOA PS15-1502.
    Contact Person for More Information: Lisa R. Williams, Public 
Health Analyst, CDC, 1600 Clifton Road NE., Mailstop E07, Atlanta, 
Georgia 30333, Telephone: (404) 639-1877.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-01769 Filed 1-29-15; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.